CUC (9158) Fundamentals 2026 — P/E 8.3x, Revenue Analysis | SniperIQ
CUC (9158) is a JP-listed Healthcare company in Medical - Care Facilities with a market capitalization of ¥23.7B, trading at ¥808.00 on the JPX. This SniperIQ fundamentals page covers CUC's valuation (P/E 8.3x, P/B 0.7x), profitability (net margin 5.3%), revenue (¥54.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is CUC's market cap?
CUC (9158) has a market capitalization of approximately ¥23.7B, trading at ¥808.00 on the JPX. Market cap moves with the live share price.
What is CUC's P/E ratio?
CUC's trailing twelve-month P/E ratio is 8.3x, with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is CUC?
CUC runs a net profit margin of 5.3%, a gross margin of 46.8%, and an operating margin of 6.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does CUC generate?
CUC reported revenue of ¥54.4B for fiscal year 2025, with net income of ¥2.9B and earnings per share (EPS) of 97.36. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does CUC pay a dividend?
CUC does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is CUC financially healthy?
CUC carries a debt-to-equity ratio of 1.58x and a current ratio of 2.03x, with a market beta of 0.25. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is CUC a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For CUC (9158) the key facts are: market cap ¥23.7B, P/E 8.3x, revenue ¥54.4B, 52-week range 686-1316. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track CUC's full fundamentals live
Get CUC's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.